Author's Reply to Comments to: Real-World Outcomes of Anti-VEGF Treatment for Retinal Vein Occlusion in Portugal
- PMID: 28862735
- DOI: 10.5301/ejo.5001015
Author's Reply to Comments to: Real-World Outcomes of Anti-VEGF Treatment for Retinal Vein Occlusion in Portugal
Comment on
-
Real-World Outcomes of Anti-VEGF Treatment for Retinal Vein Occlusion in Portugal.Eur J Ophthalmol. 2017 Nov 8;27(6):756-761. doi: 10.5301/ejo.5000943. Eur J Ophthalmol. 2017. PMID: 28315518
-
Comments to: Real-World Outcomes of Anti-VEGF Treatment for Retinal Vein Occlusion in Portugal.Eur J Ophthalmol. 2017 Nov 8;27(6):e190-e191. doi: 10.5301/ejo.5001016. Eur J Ophthalmol. 2017. PMID: 28777389 No abstract available.
Similar articles
-
Comments to: Real-World Outcomes of Anti-VEGF Treatment for Retinal Vein Occlusion in Portugal.Eur J Ophthalmol. 2017 Nov 8;27(6):e190-e191. doi: 10.5301/ejo.5001016. Eur J Ophthalmol. 2017. PMID: 28777389 No abstract available.
-
Clinical outcome after switching therapy from ranibizumab and/or bevacizumab to aflibercept in central retinal vein occlusion.Ophthalmic Res. 2015;54(3):150-6. doi: 10.1159/000439223. Epub 2015 Sep 29. Ophthalmic Res. 2015. PMID: 26413794
-
Significant Correlation between Retinal Venous Tortuosity and Aqueous Vascular Endothelial Growth Factor Concentration in Eyes with Central Retinal Vein Occlusion.PLoS One. 2015 Jul 27;10(7):e0134267. doi: 10.1371/journal.pone.0134267. eCollection 2015. PLoS One. 2015. PMID: 26214803 Free PMC article. Clinical Trial.
-
[Retinal vein occlusion: anti-VEGF treatments].J Fr Ophtalmol. 2009 Nov;32(9):679-86. doi: 10.1016/j.jfo.2009.10.002. Epub 2009 Oct 29. J Fr Ophtalmol. 2009. PMID: 19879018 Review. French.
-
Anti-vascular endothelial growth factor treatment for retinal vein occlusions.Ophthalmologica. 2012;227 Suppl 1:30-5. doi: 10.1159/000337157. Epub 2012 Apr 24. Ophthalmologica. 2012. PMID: 22517123 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources